NOODLES & CO (NDLS) Fundamental Analysis & Valuation

NASDAQ:NDLSUS65540B3033

Current stock price

8.3 USD
-0.23 (-2.7%)
Last:

This NDLS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NDLS Profitability Analysis

1.1 Basic Checks

  • In the past year NDLS has reported negative net income.
  • In the past year NDLS has reported a negative cash flow from operations.
  • In the past 5 years NDLS reported 4 times negative net income.
  • NDLS had a positive operating cash flow in 4 of the past 5 years.
NDLS Yearly Net Income VS EBIT VS OCF VS FCFNDLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

  • NDLS has a worse Return On Assets (-16.20%) than 90.48% of its industry peers.
Industry RankSector Rank
ROA -16.2%
ROE N/A
ROIC N/A
ROA(3y)-4.93%
ROA(5y)-4.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NDLS Yearly ROA, ROE, ROICNDLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

  • Looking at the Gross Margin, with a value of 22.86%, NDLS is doing worse than 83.33% of the companies in the same industry.
  • NDLS's Gross Margin has declined in the last couple of years.
  • NDLS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.5%
NDLS Yearly Profit, Operating, Gross MarginsNDLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

0

2. NDLS Health Analysis

2.1 Basic Checks

  • NDLS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NDLS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NDLS Yearly Shares OutstandingNDLS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
NDLS Yearly Total Debt VS Total AssetsNDLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • NDLS has an Altman-Z score of 0.44. This is a bad value and indicates that NDLS is not financially healthy and even has some risk of bankruptcy.
  • NDLS has a worse Altman-Z score (0.44) than 78.57% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.44
ROIC/WACCN/A
WACC8.35%
NDLS Yearly LT Debt VS Equity VS FCFNDLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 0.34 indicates that NDLS may have some problems paying its short term obligations.
  • NDLS's Current ratio of 0.34 is on the low side compared to the rest of the industry. NDLS is outperformed by 88.89% of its industry peers.
  • A Quick Ratio of 0.19 indicates that NDLS may have some problems paying its short term obligations.
  • The Quick ratio of NDLS (0.19) is worse than 94.44% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.19
NDLS Yearly Current Assets VS Current LiabilitesNDLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

0

3. NDLS Growth Analysis

3.1 Past

  • The earnings per share for NDLS have decreased by -5.28% in the last year.
EPS 1Y (TTM)-5.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.82%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y11.73%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NDLS Yearly Revenue VS EstimatesNDLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
NDLS Yearly EPS VS EstimatesNDLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

1

4. NDLS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NDLS. In the last year negative earnings were reported.
  • Also next year NDLS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NDLS Price Earnings VS Forward Price EarningsNDLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NDLS indicates a somewhat cheap valuation: NDLS is cheaper than 72.22% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.7
NDLS Per share dataNDLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. NDLS Dividend Analysis

5.1 Amount

  • NDLS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

NDLS Fundamentals: All Metrics, Ratios and Statistics

NOODLES & CO

NASDAQ:NDLS (4/6/2026, 8:00:02 PM)

8.3

-0.23 (-2.7%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-25
Earnings (Next)05-05
Inst Owners28.1%
Inst Owner Change-9.01%
Ins Owners5.78%
Ins Owner Change-0.02%
Market Cap48.56M
Revenue(TTM)N/A
Net Income(TTM)-45.45M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short Ratio1.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-64.33%
Min EPS beat(2)-135.29%
Max EPS beat(2)6.63%
EPS beat(4)1
Avg EPS beat(4)-61%
Min EPS beat(4)-135.29%
Max EPS beat(4)6.63%
EPS beat(8)3
Avg EPS beat(8)-112.91%
EPS beat(12)6
Avg EPS beat(12)-40.71%
EPS beat(16)7
Avg EPS beat(16)-42.41%
Revenue beat(2)0
Avg Revenue beat(2)-2.95%
Min Revenue beat(2)-5.82%
Max Revenue beat(2)-0.07%
Revenue beat(4)0
Avg Revenue beat(4)-2.41%
Min Revenue beat(4)-5.82%
Max Revenue beat(4)-0.07%
Revenue beat(8)0
Avg Revenue beat(8)-2.9%
Revenue beat(12)0
Avg Revenue beat(12)-3.14%
Revenue beat(16)0
Avg Revenue beat(16)-3.04%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-700%
EPS NY rev (1m)0%
EPS NY rev (3m)-700%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 8.7
EPS(TTM)-3.79
EYN/A
EPS(NY)-3.35
Fwd EYN/A
FCF(TTM)-2.65
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS84.46
BVpS-6.65
TBVpS-7.95
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -16.2%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.86%
FCFM N/A
ROA(3y)-4.93%
ROA(5y)-4.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.5%
F-Score4
Asset Turnover1.76
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 6.15
Cap/Depr 49.61%
Cap/Sales 2.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.19
Altman-Z 0.44
F-Score4
WACC8.35%
ROIC/WACCN/A
Cap/Depr(3y)146.29%
Cap/Depr(5y)115.44%
Cap/Sales(3y)7.61%
Cap/Sales(5y)5.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.17%
EPS Next Y11.73%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.82%
Revenue Next Year-4.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year328.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y18.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.6%
OCF growth 3Y-40.65%
OCF growth 5Y-24.12%

NOODLES & CO / NDLS Fundamental Analysis FAQ

What is the fundamental rating for NDLS stock?

ChartMill assigns a fundamental rating of 0 / 10 to NDLS.


Can you provide the valuation status for NOODLES & CO?

ChartMill assigns a valuation rating of 1 / 10 to NOODLES & CO (NDLS). This can be considered as Overvalued.


Can you provide the profitability details for NOODLES & CO?

NOODLES & CO (NDLS) has a profitability rating of 1 / 10.


What is the financial health of NOODLES & CO (NDLS) stock?

The financial health rating of NOODLES & CO (NDLS) is 0 / 10.


What is the earnings growth outlook for NOODLES & CO?

The Earnings per Share (EPS) of NOODLES & CO (NDLS) is expected to grow by 11.73% in the next year.